| answer text |
<p>Since the start of the COVID-19 pandemic, the UK has championed the importance
of rapid, equitable access to safe and effective vaccines. We are among the largest
donors to the COVAX Advance Market Commitment (AMC), committing £548 million, which
through match-funding leveraged $1 billion from other donors in 2020. This support
has been critical to COVAX's distribution of COVID-19 vaccines to over 130 countries
and economies, including India, and to support countries to assess vaccine introduction
readiness, develop detailed national deployment and vaccination plans, and strengthen
delivery systems.</p><p>The Foreign Secretary launched the UK-India Vaccines Hub in
December 2020, which has expanded collaboration between our two countries on vaccine
trials, regulation, and vaccination strategies. Our two vaccine task forces are in
regular contact, discussing the acceleration of the vaccine programme, target groups,
dose intervals, and the best strategies to increase vaccine confidence.</p>
|
|
